Dung-Tsa Chen

17PUBLICATIONS
120CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples and disabilityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 28, 2026
CT-Derived Radiomic Signature of MUC6 Expression Improves Guideline-Based Risk Stratification in Intraductal Papillary Mucinous Neoplasms.

|May 13, 2026
HER-2 Altered Early-Stage Non-Small Cell Lung Cancer Had Better Survival than Triple-Negative Disease.

|Dec 18, 2025
Race-based differences in serum biomarkers for cancer-associated cachexia in a diverse cohort of patients with pancreatic ductal adenocarcinoma.

Margaret A Park, Evan W Davis, Solomon Alhassan

|Dec 10, 2025
Timing of Durvalumab Consolidation and Survival in Non-Small Cell Lung Cancer: A Population-Based Analysis.

Tawee Tanvetyanon, Dung-Tsa Chen, Jhanelle E Gray

|Jun 24, 2025
The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma.

Evan W Davis, Margaret A Park, Toni L Basinski

|May 20, 2025
Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma.

Ahmad A Tarhini, Alyssa Obermayer, Sandra J Lee

Pageof 3

Frequent Collaborators

6 joint publications

Jennifer Permuth

5 joint publications

Jamie Teer

4 joint publications

Paul Stewart

4 joint publications

John M Koomen